Search Within

Brian Kushner

  1. "2021"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (4)
  3. Editorial (1)
Groups
  1. Neuroblastoma Service (13)
  2. Pediatrics, Department of (13)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  4. GSK Faculty (5)
  5. Sloan Kettering Institute Postdocs (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Shakeel Modak (8)
  2. Ellen Basu (6)
  3. Stephen Roberts (6)
  4. Nai-Kong Cheung (3)
  5. Audrey Mauguen (2)
  6. Elli Papaemmanuil (2)

More People

Years
  1. 2021 (13)
Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (3)
  3. Annals of Oncology (2)
  4. Cancers (1)
Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (2)
  4. MDPI (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of corticosteroid premedication for patients treated with the humanized GD2-binding monoclonal antibody naxitamab
    Meeting Abstract

    Mora, J.; Bear, M.; Chan, G.; Morgenstern, D. A.; Nysom, K.; Tornøe, K.; Hindsberger, C.; Kushner, B.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • ALK inhibitors for treatment of adult-onset neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kushner, B.; Roberts, S.; Basu, E.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Gundem, G.; Papaemmanuil, E.; Roberts, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease
    Meeting Abstract

    Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Naxitamab treatment of refractory/relapsed high-risk neuroblastoma (R/R HR NB); Subgroup analysis of updated interim efficacy and safety data for the registrational phase II trial
    Meeting Abstract

    Mora, J.; Bear, M.; Chi-Fung Chan, G.; Morgenstern, D.; Nysom, K.; Tornoe, K.; Losic, N.; Kushner, B.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • ALK inhibitors for treatment of adult-onset neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kushner, B. H.; Basu, E. M.; Roberts, S. S.; Modak, S.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of naxitamab in patients with refractory/relapse (R/R) high-risk neuroblastoma (HR-NB) by bone/bone marrow (BM) evaluation, potential sites of residual disease
    Meeting Abstract

    Kushner, B. H.; Morgenstern, D. A.; Nysom, K.; Bear, M. K.; Tornoe, K.; Losic, N.; Mora, J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201
    Meeting Abstract

    Mora, J.; Bear, M.; Chan, G.; Morgenstern, D. A.; Nysom, K.; Tornøe, K.; Losic, N.; Kushner, B.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Journal Article

    Shahid, S.; Kushner, B. H.; Modak, S.; Basu, E. M.; Rubin, E. M.; Gundem, G.; Papaemmanuil, E.; Roberts, S. S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save